Hu et al reported that interferon-α could reprogram glucose metabolism in HCC by acting on FosB, thereby unleashing T cell cytotoxic capacity and enhancing PD-1 blockade-induced immune responses.39JUNB and FOSB may act together on NAFLD. The gene discussed is FOSB; the disease is metabolic dysfunction-associated steatotic liver disease.